methoxyamine has been researched along with Cancer of Ovary in 1 studies
methoxyamine: analytical reagent for aldehydes and ketones; strong irritant, can probably produce methemoglobinemia; RN given refers to parent cpd; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "To improve the treatment of women with ovarian cancer, we are investigating the modulation of a prominent DNA-damaging agent, temozolomide, by manipulating the DNA base excision repair (BER) pathway via BER inhibitor, methoxyamine, and overexpression of N-methylpurine DNA glycosylase (MPG)." | 1.34 | Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. ( Fishel, ML; He, Y; Kelley, MR; Smith, ML, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fishel, ML | 1 |
| He, Y | 1 |
| Smith, ML | 1 |
| Kelley, MR | 1 |
1 other study available for methoxyamine and Cancer of Ovary
| Article | Year |
|---|---|
Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Base Sequence; Cell Line, Tumor; Dacarbazine; DNA Dama | 2007 |